Viewing StudyNCT03995212



Ignite Creation Date: 2024-05-06 @ 1:20 PM
Last Modification Date: 2024-10-26 @ 1:12 PM
Study NCT ID: NCT03995212
Status: TERMINATED
Last Update Posted: 2023-07-03
First Post: 2019-06-19

Brief Title: Study to Evaluate the Safety and Efficacy of Oral CR845 Difelikefalin in Patients With Primary Biliary Cholangitis PBC and Moderate-to-Severe Pruritus
Sponsor: Cara Therapeutics Inc
Organization: Cara Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Cholestatic Pruritus
Keywords:
Name View
Generalized pruritus View
Primary Biliary Cholangitis View
Pruritus View
CR845 View
Chronic Itch View
difelikefalin View
Itch View
Itching View